This announcement is a separate document:
易瑞生物：深圳市同致诚德明资产评估有限公司关于深圳市易瑞生物技术股份有限公司拟进行资产减值测试所涉及的固定资产公允价值项目评估报告
Shenzhen Bioeasy Biotechnology: Report on the evaluation of the fair value of fixed assets involved in the proposed asset impairment test of Shenzhen Yirui Biotechnology Co., Ltd. by Shenzhen Tongzhichengdeming Asset Appraisal Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated